or Try an Advanced Search...

    Percutaneous Coronary Intervention Stocks List

    Symbol Grade Name % Change
    LLY C Eli Lilly and Company -2.16
    NSPR F InspireMD, Inc. -0.50
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Percutaneous Coronary Intervention stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 23.02
    MEDX F Horizon Kinetics Medical ETF 14.73
    PPH C Market Vectors Pharmaceutical ETF 11.73
    IYH C iShares U.S. Healthcare ETF 11.65
    XLV C SPDR Select Sector Fund - Health Care 11.3
    View all Percutaneous Coronary Intervention ETFs...
    Compare ETFs
    Compare IHE to PPH Compare PPH to IYH Compare PPH to XLV

        Percutaneous Coronary Intervention Stocks Recent News

        Date Stock Title
        May 3 LLY Eli Lilly: Don't Overpay For Miracle Drugs
        May 2 LLY 1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
        May 2 LLY Analysts reveal Eli Lilly stock price targets after earnings
        May 2 LLY Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
        May 2 LLY Amgen Soars After CEO Gives Update on Experimental Obesity Drug
        May 2 LLY Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
        May 2 LLY Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
        May 2 LLY Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide
        May 2 LLY Earnings Season: 3 Companies Boosting Guidance
        May 2 LLY Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
        May 2 LLY Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
        May 2 LLY GLP-1 drug prices falling at UK pharmacies, clinics: report
        May 2 LLY Novo sees Wegovy sales dip on lower price, tight supply
        May 2 LLY Eli Lilly and Company (NYSE:LLY) Just Released Its First-Quarter Earnings: Here's What Analysts Think
        May 2 LLY Novo Nordisk Hikes Guidance as Weight-Loss Drug Sales Surge. Why the Stock’s Falling.
        May 2 LLY Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
        May 2 LLY Here's Why Eli Lilly Stock Remains a Screaming Buy
        May 2 LLY UPDATE 3-Novo Nordisk raises outlook fuelled by obesity drug demand
        May 2 LLY Novo Nordisk raises outlook fuelled by obesity drug demand
        May 2 LLY FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes
        Percutaneous Coronary Intervention

        Percutaneous Coronary Intervention (PCI) is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. It involves inserting a catheter into a blood vessel in the arm or leg and guiding it to the narrowed or blocked coronary artery. A balloon is then inflated to widen the artery and a stent is inserted to keep it open. PCI can improve blood flow to the heart and reduce the risk of a heart attack.

        Browse All Tags